125 related articles for article (PubMed ID: 15224168)
1. The development of bone metastases as the first sign of metastatic spread in patients with primary solid tumours.
Papadakis SA; Mitsitsikas TC; Markakidis S; Minas MK; Tripsiannis G; Tentes AA
Int Orthop; 2004 Apr; 28(2):102-5. PubMed ID: 15224168
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer.
Diessner J; Wischnewsky M; Stüber T; Stein R; Krockenberger M; Häusler S; Janni W; Kreienberg R; Blettner M; Schwentner L; Wöckel A; Bartmann C
BMC Cancer; 2016 May; 16():307. PubMed ID: 27175930
[TBL] [Abstract][Full Text] [Related]
3. Effect of the types of pretreatment imaging modalities on the treatment response to palliative radiation for painful bone metastases from solid cancer: a single-center retrospective analysis.
Wada Y; Anbai A; Kumagai S; Okuyama E; Hatakeyama K; Takagi N; Hashimoto M
Radiat Oncol; 2019 Jun; 14(1):98. PubMed ID: 31174548
[TBL] [Abstract][Full Text] [Related]
4. Prevention of bone metastases in patients with high-risk nonmetastatic prostate cancer treated with zoledronic acid: efficacy and safety results of the Zometa European Study (ZEUS).
Wirth M; Tammela T; Cicalese V; Gomez Veiga F; Delaere K; Miller K; Tubaro A; Schulze M; Debruyne F; Huland H; Patel A; Lecouvet F; Caris C; Witjes W
Eur Urol; 2015 Mar; 67(3):482-91. PubMed ID: 24630685
[TBL] [Abstract][Full Text] [Related]
5. Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer.
Gandaglia G; Karakiewicz PI; Briganti A; Passoni NM; Schiffmann J; Trudeau V; Graefen M; Montorsi F; Sun M
Eur Urol; 2015 Aug; 68(2):325-34. PubMed ID: 25108577
[TBL] [Abstract][Full Text] [Related]
6. Routine interval computed tomography to detect new soft-tissue disease might be unnecessary in patients with androgen-independent prostate cancer and metastasis only to bone.
Wu SL; Jones E; Gulley JL; Arlen PM; Chen CC; Figg WD; Dahut WL
BJU Int; 2007 Mar; 99(3):525-8. PubMed ID: 17155971
[TBL] [Abstract][Full Text] [Related]
7. Serum C-telopeptide levels predict the incidence of skeletal-related events in cancer patients with secondary bone metastases.
López-Carrizosa MC; Samper-Ots PM; Pérez AR
Clin Transl Oncol; 2010 Aug; 12(8):568-73. PubMed ID: 20709654
[TBL] [Abstract][Full Text] [Related]
8. Bone metastases as the first manifestation of a tumour.
Barón MG; de la Gándara I; Espinosa E; de Paredes ML; Zamora P; Mondéjar JL
Int Orthop; 1991; 15(4):373-6. PubMed ID: 1725677
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of early versus late onset of bone metastasis in patients with carcinoma of the ovary, peritoneum and fallopian tube.
Sehouli J; Olschewski J; Schotters V; Fotopoulou C; Pietzner K
Ann Oncol; 2013 Dec; 24(12):3024-8. PubMed ID: 24130264
[TBL] [Abstract][Full Text] [Related]
10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
11. Survival after bone metastasis by primary cancer type: a Danish population-based cohort study.
Svensson E; Christiansen CF; Ulrichsen SP; Rørth MR; Sørensen HT
BMJ Open; 2017 Sep; 7(9):e016022. PubMed ID: 28893744
[TBL] [Abstract][Full Text] [Related]
12. Bone metastasis and skeletal-related events in patients with solid cancer: A Korean nationwide health insurance database study.
Hong S; Youk T; Lee SJ; Kim KM; Vajdic CM
PLoS One; 2020; 15(7):e0234927. PubMed ID: 32678818
[TBL] [Abstract][Full Text] [Related]
13. Incidence, prevalence, and outcomes of systemic malignancy with bone metastases.
Jiang W; Rixiati Y; Zhao B; Li Y; Tang C; Liu J
J Orthop Surg (Hong Kong); 2020; 28(2):2309499020915989. PubMed ID: 32634071
[TBL] [Abstract][Full Text] [Related]
14. Developing an Evidence-based Followup Schedule for Bone Sarcomas Based on Local Recurrence and Metastatic Progression.
Cipriano C; Griffin AM; Ferguson PC; Wunder JS
Clin Orthop Relat Res; 2017 Mar; 475(3):830-838. PubMed ID: 27339121
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma.
Carlinfante G; Vassiliou D; Svensson O; Wendel M; Heinegård D; Andersson G
Clin Exp Metastasis; 2003; 20(5):437-44. PubMed ID: 14524533
[TBL] [Abstract][Full Text] [Related]
16. A retrospective study of first indicators of breast cancer recurrence.
Pivot X; Asmar L; Hortobagyi GN; Theriault R; Pastorini F; Buzdar A
Oncology; 2000 Apr; 58(3):185-90. PubMed ID: 10765118
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological features and prognosis of patients in endometrial cancer with bone metastases].
Jiang F; Ren T; Cheng NH; Cao DY; Yang JX; Wu M; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2019 Jul; 54(7):452-457. PubMed ID: 31365957
[No Abstract] [Full Text] [Related]
18. Breast cancer recurrence, bone metastases, and visceral metastases in women with stage II and III breast cancer in Denmark.
Cronin-Fenton D; Kjærsgaard A; Nørgaard M; Amelio J; Liede A; Hernandez RK; Sørensen HT
Breast Cancer Res Treat; 2018 Jan; 167(2):517-528. PubMed ID: 28948396
[TBL] [Abstract][Full Text] [Related]
19. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
20. Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States.
Hernandez RK; Wade SW; Reich A; Pirolli M; Liede A; Lyman GH
BMC Cancer; 2018 Jan; 18(1):44. PubMed ID: 29306325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
